Abeona Shares Higher After Pricing Stock Offering -- Biotech Movers

The clinical-stage biopharmaceutical firm said Oct. 16 it has priced an underwritten public offering of five million shares at $16 apiece.
Stocks quotes in this article: ABEO, ARDX, INSY

Shares of Abeona Therapeutics Inc. (ABEO) rose 1.8% to $17 in premarket trading on Tuesday, Oct. 17, after the company priced an underwritten public offering of five million shares at $16 apiece, which would generate gross proceeds of $80 million. Abeona has also given underwriters a 30-day option to buy up to an additional 750,000 shares.

Abeona said it plans to use the net proceeds for working capital and corporate purposes.

Meanwhile, shares of Ardelyx Inc. (ARDX) were up 4.6% to $6.70 after closing at $6.40 on Monday, down 12%.

The Fremont, Calif.-based firm on Monday morning said data from preclinical studies have shown that "tenapanor works to reduce abdominal pain caused by irritable bowel syndrome with constipation (IBS-C) through the inhibition of TRPV-1 dependent signaling."

Among the other biotech stock movers was Insys Therapeutics Inc. (INSY) , up 3.8% to $7.70.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.
TAGS: Investing | U.S. Equity | Healthcare | Drug Approvals | Stocks

More from Healthcare

Medtronic Hits Our Price Target: Time to Take Profits?

Bruce Kamich

A follow-up to our story in June.

2 Downtrodden Small Biotechs That Are Showing Signs of Life

Bret Jensen

T2 Biosystems and Replimune Group have spurted higher in the last couple weeks, with the former doubling in value on encouraging news.

With CVS, Bulls Still Have Their Work Cut Out for Them

Timothy Collins

The company appears to be combating the risk of possible cost-cutting reform with their continued diversification.

Separating Quality Dividend-Paying Companies From the Wannabes: Part 2

Chris Versace

We run Medical Properties Trust through our dividend-metric gauntlet to see whether the healthcare REIT can maintain its payout pace.

CVS Health Continues to Move Higher - New Stop Recommendation

Bruce Kamich

CVS continues to move in the right direction for the bulls.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight